Stokes Bio | GenomeWeb

Stokes Bio

The company also said it expects continued growth in this area due in part to the introduction later this year of microfluidics-based PCR technology obtained through last year's acquisition of Stokes Bio.

Startups QuantaLife and Inostics join more established outfits RainDance Technologies and Life Technologies in exploring the digital PCR market, but all players will need to negotiate what is sure to be a complex intellectual property landscape.

Digital PCR may be on the verge of becoming nearly as ubiquitous as its predecessor, quantitative real-time PCR, thanks to the integration of empowering nanoscale and microfluidic technologies.

Life Tech officials said that Stokes Bio's microfluidics-based technology platform will enable high-throughput, PCR-based genetic analyses for a variety of applications, particularly in the area of agricultural biology.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.